Acelyrin Inc. (SLRN)
Acelyrin Statistics
Share Statistics
Acelyrin has 100.71M shares outstanding. The number of shares has increased by 1.7% in one year.
| Shares Outstanding | 100.71M |
| Shares Change (YoY) | 1.7% |
| Shares Change (QoQ) | 0.38% |
| Owned by Institutions (%) | 88.08% |
| Shares Floating | 73.01M |
| Failed to Deliver (FTD) Shares | 18.65K |
| FTD / Avg. Volume | 0.84% |
Short Selling Information
The latest short interest is 6.53M, so 6.51% of the outstanding shares have been sold short.
| Short Interest | 6.53M |
| Short % of Shares Out | 6.51% |
| Short % of Float | 8.92% |
| Short Ratio (days to cover) | 4.09 |
Valuation Ratios
The PE ratio is -1.26 and the forward PE ratio is -0.86. Acelyrin's PEG ratio is 0.02.
| PE Ratio | -1.26 |
| Forward PE | -0.86 |
| PS Ratio | 0 |
| Forward PS | 2.9 |
| PB Ratio | 0.68 |
| P/FCF Ratio | -1.02 |
| PEG Ratio | 0.02 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Acelyrin.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 18.1, with a Debt / Equity ratio of 0.01.
| Current Ratio | 18.1 |
| Quick Ratio | 18.1 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | -0.02 |
| Debt / FCF | -0.02 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-2.99M |
| Employee Count | 83 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -58.22% in the last 52 weeks. The beta is 1.14, so Acelyrin's price volatility has been higher than the market average.
| Beta | 1.14 |
| 52-Week Price Change | -58.22% |
| 50-Day Moving Average | 2.37 |
| 200-Day Moving Average | 4.14 |
| Relative Strength Index (RSI) | 57.17 |
| Average Volume (20 Days) | 2.22M |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | -316.26M |
| Net Income | -248.23M |
| EBITDA | -316.26M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -2.5 |
Balance Sheet
The company has 73.89M in cash and 6.27M in debt, giving a net cash position of 67.62M.
| Cash & Cash Equivalents | 73.89M |
| Total Debt | 6.27M |
| Net Cash | 67.62M |
| Retained Earnings | -736.95M |
| Total Assets | 491.14M |
| Working Capital | 454.41M |
Cash Flow
In the last 12 months, operating cash flow was -303.92M and capital expenditures -1.25M, giving a free cash flow of -305.17M.
| Operating Cash Flow | -303.92M |
| Capital Expenditures | -1.25M |
| Free Cash Flow | -305.17M |
| FCF Per Share | -3.07 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SLRN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for SLRN is $6, which is 116.6% higher than the current price. The consensus rating is "Hold".
| Price Target | $6 |
| Price Target Difference | 116.6% |
| Analyst Consensus | Hold |
| Analyst Count | 5 |
Scores
| Altman Z-Score | 1.5 |
| Piotroski F-Score | 1 |